Skip to main content
Log in

Intensive Blood Pressure Lowering and DWI Lesions in Intracerebral Hemorrhage: Exploratory Analysis of the ATACH-2 Randomized Trial

  • Original work
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

With the increasing use of magnetic resonance imaging in the assessment of acute intracerebral hemorrhage, diffusion-weighted imaging hyperintense lesions have been recognized to occur at sites remote to the hematoma in up to 40% of patients. We investigated whether blood pressure reduction was associated with diffusion-weighted imaging hyperintense lesions in acute intracerebral hemorrhage and whether such lesions are associated with worse clinical outcomes by analyzing imaging data from a randomized trial.

Methods

We performed exploratory subgroup analyses in an open-label randomized trial that investigated acute blood pressure lowering in 1000 patients with intracerebral hemorrhage between May 2011 and September 2015. Eligible participants were assigned to an intensive systolic blood pressure target of 110–139 mm Hg versus 140–179 mm Hg with the use of intravenous nicardipine. Of these, 171 patients had requisite magnetic resonance imaging sequences for inclusion in these subgroup analyses. The primary outcome was the presence of diffusion-weighted imaging hyperintense lesions. Secondary outcomes included death or disability and serious adverse event at 90 days.

Results

Diffusion-weighted imaging hyperintense lesions were present in 25% of patients (mean age 62 years). Hematoma volume > 30 cm3 was an adjusted predictor (adjusted relative risk 2.41, 95% confidence interval 1.00–5.80) of lesion presence. Lesions occurred in 25% of intensively treated patients and 24% of standard treatment patients (relative risk 1.01, 95% confidence interval 0.71–1.43, p = 0.97). Patients with diffusion-weighted imaging hyperintense lesions had similar frequencies of death or disability at 90 days, compared with patients without lesions.

Conclusions

Randomized assignment to intensive acute blood pressure lowering did not result in a greater frequency of diffusion-weighted imaging hyperintense lesion. Alternative mechanisms of diffusion-weighted imaging hyperintense lesion formation other than hemodynamic fluctuations need to be explored.

Clinical trial registration ClinicalTrials.gov (Ref. NCT01176565; https://clinicaltrials.gov/ct2/show/NCT01176565).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology. 2009;72:1230–5.

    Article  CAS  Google Scholar 

  2. Prabhakaran S, Gupta R, Ouyang B, John S, Temes RE, Mohammad Y, et al. Acute brain infarcts after spontaneous intracerebral hemorrhage: a diffusion-weighted imaging study. Stroke. 2010;41:89–94.

    Article  Google Scholar 

  3. Gregoire SM, Charidimou A, Gadapa N, Dolan E, Antoun N, Peeters A, et al. Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain. 2011;134:2376–86.

    Article  Google Scholar 

  4. Kang DW, Han MK, Kim HJ, Yun SC, Jeon SB, Bae HJ, et al. New ischemic lesions coexisting with acute intracerebral hemorrhage. Neurology. 2012;79:848–55.

    Article  Google Scholar 

  5. Auriel E, Gurol ME, Ayres A, Dumas AP, Schwab KM, Vashkevich A, et al. Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology. 2012;79:2335–41.

    Article  CAS  Google Scholar 

  6. Garg RK, Liebling SM, Maas MB, Nemeth AJ, Russell EJ, Naidech AM. Blood pressure reduction, decreased diffusion on mri, and outcomes after intracerebral hemorrhage. Stroke. 2012;43:67–71.

    Article  Google Scholar 

  7. Menon RS, Burgess RE, Wing JJ, Gibbons MC, Shara NM, Fernandez S, et al. Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol. 2012;71:199–205.

    Article  Google Scholar 

  8. Arsava EM, Kayim-Yildiz O, Oguz KK, Akpinar E, Topcuoglu MA. Elevated admission blood pressure and acute ischemic lesions in spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2013;22:250–4.

    Article  Google Scholar 

  9. Butcher KS, Jeerakathil T, Hill M, Demchuk AM, Dowlatshahi D, Coutts SB, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44:620–6.

    Article  Google Scholar 

  10. Gioia LC, Kate M, Choi V, Sivakumar L, Jeerakathil T, Kosior J, et al. Ischemia in intracerebral hemorrhage is associated with leukoaraiosis and hematoma volume, not blood pressure reduction. Stroke. 2015;46:1541–7.

    Article  Google Scholar 

  11. Kidwell CS, Rosand J, Norato G, Dixon S, Worrall BB, James ML, et al. Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage. Neurology. 2017;88(8):782–8.

    Article  Google Scholar 

  12. Tsai YH, Lee MH, Weng HH, Chang SW, Yang JT, Huang YC. Fate of diffusion restricted lesions in acute intracerebral hemorrhage. PLoS One. 2014;9:e105970.

  13. van Veluw SJ, Shih AY, Smith EE, Chen C, Schneider JA, Wardlaw JM, et al. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol. 2017;16:730–40.

    Article  Google Scholar 

  14. van Veluw SJ, Lauer A, Charidimou A, Bounemia N, Xiong L, Boulouis G, et al. Evolution of dwi lesions in cerebral amyloid angiopathy: evidence for ischemia. Neurology. 2017;89:2136–42.

    Article  Google Scholar 

  15. Wu B, Yao X, Lei C, Liu M, Selim MH. Enlarged perivascular spaces and small diffusion-weighted lesions in intracerebral hemorrhage. Neurology. 2015;85:2045–52.

    Article  Google Scholar 

  16. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (atach) ii: design, methods, and rationale. Neurocrit Care. 2011;15:559–76.

    Article  CAS  Google Scholar 

  17. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43.

    Article  Google Scholar 

  18. Goldstein J, Brouwers H, Romero J, McNamara K, Schwab K, Greenberg S, et al. Score-it: the spot sign score in restricting ich growth horizontal line an atach-ii ancillary study. J Vasc Interv Neurol. 2012;5:20–5.

    PubMed  PubMed Central  Google Scholar 

  19. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.

    Article  Google Scholar 

  20. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.

    Article  Google Scholar 

  21. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for age-related white matter changes applicable to mri and ct. Stroke. 2001;32:1318–22.

    Article  CAS  Google Scholar 

  22. Oliveira-Filho J, Ay H, Shoamanesh A, Park KY, Avery R, Sorgun M, et al. Incidence and etiology of microinfarcts in patients with ischemic stroke. J Neuroimaging. 2018;28:406–11.

    Article  Google Scholar 

  23. Murthy SB, Cho SM, Gupta A, Shoamanesh A, Navi BB, Avadhani R, et al. A pooled analysis of diffusion-weighted imaging lesions in patients with acute intracerebral hemorrhage. JAMA Neurol. 2020;77:1–9.

    Article  Google Scholar 

  24. Ye XH, Cai XL, Nie DL, Chen YJ, Li JW, Xu XH, et al. Stress-induced hyperglycemia and remote diffusion-weighted imaging lesions in primary intracererbal hemorrhage. Neurocrit Care. 2020;32:427–36.

    Article  CAS  Google Scholar 

  25. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiygari V, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–10.

    Article  CAS  Google Scholar 

  26. Shoamanesh A, Morotti A, Romero JM, Oliveira-Filho J, Schlunk F, Jessel MJ, et al. Cerebral microbleeds and the effect of intensive blood pressure reduction on hematoma expansion and functional outcomes: a secondary analysis of the atach-2 randomized clinical trial. JAMA Neurol. 2018;75:850–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Contributions

All authorship requirements have been met, and the final manuscript was approved by all authors. Study conception and design: AS, CC, AIQ, JR, JNG. Acquisition of data: AS, CC, AM, JR, JOF, FS, MJ, AA, AV, MRA, RHM. Administrative support: MJ, AA, AV, KS. Statistical analysis and interpretation of data: AS, CC, RHM, JR, JNG. Drafting of manuscript: AS. Critical revisions: AS, CC, AM, JR, JOF, FS, MJ, KB, LG, AA, AV, MRA, KS, MRA, RHM, AIQ, SMG, JR, JNG. Study supervision/funding: JNG, JR, AIQ.

Corresponding author

Correspondence to Ashkan Shoamanesh.

Ethics declarations

Source of support

Supported by grants (National Institutes of Health - National Institute of Neurological Disorders and Stroke (NINDS) R01NS073344, to Dr. Rosand and U01-NS062091, to Dr. Qureshi). Chiesi USA and Astellas Pharma supplied intravenous nicardipine for use during the trial but had no other role in the design or conduct of the ATACH-2 trial or in this analysis/article. The National Institutes of Health, Chiesi USA, and Astellas Pharma had no involvement in the design, analyses, interpretation, or drafting of this report.

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval/informed consent

The ATACH-2 protocol and consent forms were approved by the institutional review board or equivalent ethics committee at each participating site, and all participants or their legally authorized representative provided written informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 36 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shoamanesh, A., Cassarly, C., Morotti, A. et al. Intensive Blood Pressure Lowering and DWI Lesions in Intracerebral Hemorrhage: Exploratory Analysis of the ATACH-2 Randomized Trial. Neurocrit Care 36, 71–81 (2022). https://doi.org/10.1007/s12028-021-01254-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-021-01254-9

Keywords

Navigation